Maravai LifeSciences Holdings, Inc.

MRVI· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$6.42-2.28%

2026-08-03

Financials

Valuation Metrics

Maravai LifeSciences Holdings, Inc.'s Market Cap is $2.37B. At end of 2025 it was $471M. Ranked #1942 of 3,112 in US market (top 62%), #725 of 1,445 on NASDAQ (top 50%), #119 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 44%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$2.37B	US#1,942/3,112 Sec#119/269
Revenue	$205M	US#2,675/3,112 Sec#113/269
Net Income	$-105M	US—/3,112 Sec—/269
Total Assets	$713M	US#2,595/3,112 Sec#124/269
Net Assets	$212M	US#2,721/3,112 Sec#195/269
Value
P/B	11.19x	US#2,652/3,112 Sec#210/269
P/S	11.57x	US#2,700/3,112 Sec#127/269
FCF Yield	-2.19%	US—/3,112 Sec—/269
Profitability
ROE	-49.42%	US#2,737/3,112 Sec#172/269
ROA	-14.66%	US#2,715/3,112 Sec#112/269
Op. Margin	21.93%	US#804/3,112 Sec#38/269
Revenue Growth	40.53%	US#371/3,112 Sec#60/269
Financial Health
Debt Ratio	162.66%	US#1,576/3,112 Sec#191/269
Total Debt	$271M	US#2,079/3,112 Sec#81/269
FCF	$-52M	US#2,469/3,112 Sec#114/269
Cash	$166M	US#1,865/3,112 Sec#134/269
Current Ratio	5.91x	US#407/3,112 Sec#129/269
Performance
1Y Return	189.19%	US#117/3,112 Sec#42/269
1M Return	6.29%	US#835/3,112 Sec#32/269
From 52W High	-13.71%	US#1,330/3,112 Sec#78/269
1Y MDD	-29.76%	US#1,366/3,112 Sec#87/269
Trading
Volume	1,994,841 shares	US#886/3,112 Sec#78/269
Trading Value	$13M	US#2,220/3,112 Sec#175/269
Per Share
EPS	$-0.90	US—/3,112 Sec—/269
BPS	$1.46	US#2,569/3,112 Sec#187/269